Mimedx (MDXG) EBIT Margin (2011 - 2026)
Mimedx recorded quarterly EBIT Margin of 27.21% in Q1 2026, down 252.44% quarter-over-quarter from 17.85% in Q4 2025, and down 3656.0% year-over-year from 0.77% in Q1 2025.
Mimedx's EBIT Margin history runs 16 years deep, the most recent figure standing at 27.21% for Q1 2026.
- In Q1 2026, EBIT Margin fell 3656.0% year-over-year to 27.21%; the TTM figure through Mar 2026 stood at 10.17% (down 513.0% YoY), while the FY2025 annual figure was 15.26%, down 161.0% from the prior year.
- EBIT Margin came in at 27.21% for Q1 2026 at Mimedx, down from 17.85% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 26.89% in Q2 2024 to a low of 27.21% in Q1 2026.
- A 5-year average of 6.97% and a median of 13.28% in 2024 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin jumped 2775 bps in 2023 and plunged 3656 bps in 2026, its largest moves.
- Mimedx's EBIT Margin stood at 15.21% in 2022, then grew by 17 bps to 17.84% in 2023, then sank by 33 bps to 11.9% in 2024, then soared by 50 bps to 17.85% in 2025, then tumbled by 252 bps to 27.21% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 27.21%, 17.85%, and 19.51% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -27.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.21% |
| Dec 31, 2025 | 17.85% |
| Sep 30, 2025 | 19.51% |
| Jun 30, 2025 | 12.55% |
| Mar 31, 2025 | 9.35% |
| Dec 31, 2024 | 11.90% |
| Sep 30, 2024 | 13.28% |
| Jun 30, 2024 | 26.89% |
| Mar 31, 2024 | 15.58% |
| Dec 31, 2023 | 17.84% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 13.34% |
| Mar 31, 2023 | -0.47% |
| Dec 31, 2022 | 15.21% |
| Sep 30, 2022 | -10.49% |
| Jun 30, 2022 | -14.41% |
| Mar 31, 2022 | -15.79% |
| Dec 31, 2021 | 2.53% |
| Sep 30, 2021 | -1.70% |
| Jun 30, 2021 | -0.60% |
| Mar 31, 2021 | -11.43% |
| Dec 31, 2020 | -23.47% |
| Sep 30, 2020 | -15.10% |
| Jun 30, 2020 | -10.92% |
| Mar 31, 2020 | -22.26% |
| Dec 31, 2019 | -6.38% |
| Sep 30, 2019 | 15.98% |
| Jun 30, 2019 | -25.32% |
| Mar 31, 2019 | -20.15% |
| Dec 31, 2018 | -9.66% |
| Sep 30, 2018 | 0.43% |
| Jun 30, 2018 | 1.76% |
| Mar 31, 2018 | 3.53% |
| Dec 31, 2017 | 27.30% |
| Sep 30, 2017 | 10.53% |
| Jun 30, 2017 | 8.96% |
| Mar 31, 2017 | 8.99% |
| Dec 31, 2016 | -12.66% |
| Sep 30, 2016 | 7.30% |
| Jun 30, 2016 | 6.21% |
| Mar 31, 2016 | 2.75% |
| Dec 31, 2015 | 14.95% |
| Sep 30, 2015 | 13.70% |
| Jun 30, 2015 | 12.37% |
| Mar 31, 2015 | 10.42% |
| Dec 31, 2014 | 11.76% |
| Sep 30, 2014 | 11.13% |
| Jun 30, 2014 | -1.53% |
| Mar 31, 2014 | -4.56% |
| Dec 31, 2013 | -7.85% |
| Sep 30, 2013 | -1.59% |
| Jun 30, 2013 | -5.51% |
| Mar 31, 2013 | -1.96% |
| Dec 31, 2012 | -9.25% |
| Sep 30, 2012 | -45.70% |
| Jun 30, 2012 | -2.41% |
| Mar 31, 2012 | -17.04% |
| Dec 31, 2011 | -92.43% |
| Sep 30, 2011 | -76.78% |
| Jun 30, 2011 | -125.24% |
| Mar 31, 2011 | -312.06% |